Overview

Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint

Status:
Terminated
Trial end date:
2019-06-06
Target enrollment:
0
Participant gender:
All
Summary
This study will examine the effectiveness of a single cortisone injection in patients with shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors to help predict how a patient with shoulder osteoarthritis will respond to a cortisone injection utilizing ultrasound guidance.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Florida
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Criteria
Inclusion Criteria:

- Patients with a diagnosis of symptomatic primary osteoarthritis of the shoulder will
be recruited from the patient population seeking treatment at the Orthopaedics Sports
Medicine Institute.

- those who have failed previous treatment including over-the-counter analgesics and
activity modification

- have elected to receive a medically-indicated, ultrasound-guided IACSI in the
shoulder.

Exclusion Criteria:

- Patients will be excluded from the study for any of the following reasons:

- Post traumatic osteoarthritis

- Inflammatory osteoarthritis

- Imaging confirmed rotator cuff tear

- Prior ipsilateral shoulder surgery

- Memory loss or inability to complete study measures

- History of allergy to injection medications

- Diabetic patients with patient-reported fasting blood glucose >200

- Prior injection in the ipsilateral shoulder within three months